Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study

Télécharger : Article

Lien : ICI

Thomas Pierret, Jean-Bernard Auliac, Charles Ricordel, Catherine Daniel, Jessica Nguyen, Florian Guisier, Aurélie Swalduz, Hubert Curcio, Anne Laure Desage, Laurence Bigay-Game, Eric Huchot, Lionel Falchero, Hélène Doubre, Olivier Bylicki, Christos Chouaïd, and Laurent Greillier

 

 

Development of an externally controlled trial from a single-arm study to assess first-line immunochemotherapy in advanced large cell neuroendocrine lung carcinomas: a study protocol from the FIRST-NEC GFPC 01-2022 trial

Télécharger : Article

Aymeric De Montfort, David Pérol, Audrey Lupo-Mansuet, Laurent Greillier, Julien Gautier, Chantal Decroisette, Sylvie Chabaud, Dominique Arpin, Luc Odier

 

Association of sleep-related hypoxemia with survival in patients with non-small cell lung cancer – the NEOSAS-GFPC study group

Télécharger : Article

Lien : ICI

Grégoire Justeau, Laurent Greillier, Florent Vinas, Lionel Falchero, Olivier Bylicki, Marie Bernardi, Francis Martin, Isabelle Simon, Didier Debieuvre, Chrystèle Locher, Acya Bizieux-Thaminy, Virginie Levrat, Stéphanie Fry, Camille Guguen, Frédéric Goutorbe, Philippe Masson, Franck Soyez, Christos Chouaid, Patrick Saulnier, Frédéric Gagnadoux

 

 

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review

Télécharger : Article

Lien : ICI

Hervé Bischoff, Sébastien Gendarme, Laura Somme, Christos Chouaid, Roland Schott